A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus

Completed · Phase 2

Conditions studied: Discoid Lupus Erythematosus

In brief

The purpose of this double-masked, pilot trial is to determine whether 20 percent thalidomide ointment is safe and effective for the treatment of chronic discoid lupus erythematosus (CDLE) when used under an occlusive dressing. Seventeen patients with two similar lesions will have lesions randomized to receive either intervention or placebo therapy.

Key facts

Study ID
NCT00001680
Run by
National Cancer Institute (NCI)
People needed
17
Starts
1997-10-01
Expected to finish
2001-07-01
Last updated by the study team
2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.